CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boylan, M. O.
Right arrow Articles by Zarbl, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boylan, M. O.
Right arrow Articles by Zarbl, H.

Cell Growth & Differentiation, Vol 7, Issue 6 725-735, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line

MO Boylan, M Athanassiou, B Houle, Y Wang and H Zarbl
Division of Toxicology, Massachusetts Institute of Technology, Cambridge 02139, USA.

Two nontransformed revertants of HeLa cells, designated HA and HF, were isolated using a selection procedure based on prolonged retention of the fluorescent dye rhodamine 123 within the mitochondria of HeLa (ATCC CCL2) cells versus normal epithelial cells. Unlike the parental HeLa cells, the revertants expressed markedly reduced levels of the bone-liver-kidney, placental, and intestinal isoforms of alkaline phosphatase, exhibited a flat nonrefractile morphology, and failed to grow in suspension culture. The revertant clones had > 100-fold reduced cloning efficiencies in semisolid medium relative to HeLa cells and failed to induce s.c. tumors when injected into nude mice. Both revertant clones have retained nontransformed phenotypes after 5 years of continuous culture. Southern blot analyses performed with human papillomavirus 18-specific DNA probes indicated that the integrated viral sequences present in HeLa cells remained intact in the revertants. Furthermore, the level of the polycistronic mRNAs encoding the viral E6 and E7 oncogenes were comparable in the parental HeLa cell line and the revertants. Western blot analyses of immunoprecipitated human papillomavirus 18 E6 and E7 proteins further demonstrated that the levels of these viral oncoproteins were comparable in HeLa cells and revertants. Infection with helper-free, defective retroviruses that express E6, E7 or E6 and E7 oncogenes failed to retransform the revertants, suggesting that their nontransformed phenotype did not result from mutations in these viral oncogenes. Cell fusion experiments indicated that the revertant phenotypes of HA and HF cells resulted from mutations in cellular genes that activate one or more tumor suppressor genes.


This article has been cited by other articles:


Home page
Cancer Genomics ProteomicsHome page
T. J. FAWCETT, M. L. PARRY, and G. BLANCK
A Novel Approach to Evaluating Cancer Driver Gene Mutation Densities: Cytoskeleton-related Gene Candidates
Cancer Genomics Proteomics, November 1, 2015; 12(6): 283 - 290.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Ke, R. Sundaram, G. Liu, J. Chionis, W. Fan, C. Rogers, T. Awad, M. Grifman, D. Yu, F. Wong-Staal, et al.
Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway
Mol. Cancer Ther., June 1, 2007; 6(6): 1840 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Ke, G. Claassen, D.-H. Yu, A. Albers, W. Fan, P. Tan, M. Grifman, X. Hu, K. DeFife, V. Nguy, et al.
Nuclear Hormone Receptor NR4A2 Is Involved in Cell Transformation and Apoptosis
Cancer Res., November 15, 2004; 64(22): 8208 - 8212.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
M. Athanassiou, Y. Hu, L. Jing, B. Houle, H. Zarbl, and A. M. Mikheev
Stabilization and Reactivation of the p53 Tumor Suppressor Protein in Nontumorigenic Revertants of HeLa Cervical Cancer Cells
Cell Growth Differ., November 1, 1999; 10(11): 729 - 737.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.